CM Life Sciences II, Inc. is a blank check company, which engages in seeking a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on December 15, 2020 and is headquartered in New York, NY.
CEO: Dr. Roy Smythe
Market: NASDAQ
Listing Date: 02/23/2021